India - Letters Patent Appeal Not Maintainable Against Orders Passed Under Section 91 Of The Trade Marks Act, Gujarat High ...

India - Trademark Infringement Suits Cannot Be Tried By Courts Below District Court: Kerala High Court Decides. Legal News ...

This page may contain advertisements. There are moments when you glance in the mirror in the evening, notice the dryness or lack of firmness around your eyes, and suddenly start searching for the ...

This page may contain advertisements. "Should I buy it on Rakuten or the official site?" It's easy to get confused. When you ...

La pobreza se ha medido tradicionalmente a través de la renta disponible. Es una medida útil, pero tiene una limitación clara ...

Index removal puts Pola Orbis Holdings in focus Pola Orbis Holdings (TSE:4927) has been removed from the FTSE All-World Index in USD terms, a development that can prompt passive funds to adjust ...

Macrocycles are a large ring-shaped molecule that have metabolic stability and an ability to conduct protein-protein interactions that small molecules cannot. Credit: theromb/Shutterstock.com. Novo ...

The Danish drugmaker said the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending marketing authorization for Frehemgo.

Novo expects to launch FREHEMGO in the first European countries in Fourth Quarter 2026 and broadly across the EU starting early 2027. The CHMP recommendation is based on the FRONTIER trial programme.

The multi-drug partnership with Orbis Medicines—which Novo Holdings has backed since the biotech’s seed rounds—is focused on cardiometabolic targets, but the technology at the center of the deal could ...

Novo has signed a drug discovery and licensing deal with Orbis Medicines worth up to $1.4bn. The partnership will focus on new oral treatments for cardiometabolic diseases and combines Novo’s ...

Agreement includes up to USD 1.4 billion with upfront and potential future milestone payments plus tiered royalties Novo will also make a strategic investment in Orbis Medicines Collaboration seeks to ...